Start / Plenary Session – inactive due to federal service / 1 03 rwe right to try talazoparib nivolumab and dr andrae vandross

Plenary Session – inactive due to federal service

1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross

66 min • 21 augusti 2018

We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.

Senaste avsnitt

CABINET - trial - Cabozantinib for NET

20 februari | 19 min

CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!

19 februari | 39 min

Why the NIH is a broken funding system

19 februari | 32 min

Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints

19 februari | 23 min

Trump is breaking media brains / NIH cuts indirect payments and scientists freak out

19 februari | 27 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00